Below are the best videos we could find on Psilocybin featuring fellowship and community.
CLEAR ALL
Can LSD and psilocybin provide relief to people suffering from difficult-to-treat conditions such as depression and anxiety? Robin Carhart-Harris is a neuroscientist and head of the Imperial Centre for Psychedelic Research, which builds on over a decade of pioneering work psychedelic research,...
1
The UK is experiencing a psychedelic renaissance.
A small community of experimental psychotherapists—along with self-medicating users—have been using acid and mushrooms to treat mental health conditions for years, with promising results.
Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment.
Terence McKenna talks about his personal process for using psilocybin mushrooms, attempts to describe some of the experiences he has had while on psychedelics, and what to do if you're experiencing a "bad trip" - he suggests singing.
If your ego had a "location" in the brain, it would be the default mode network, where much of your self-critical mind chatter happens. Taking psychedelics down-regulates this brain network.
Johns Hopkins Researcher Mary Cosimano shares promising results from clinical trials of guided psilocybin sessions being utilized in the treatment of addiction, depression, and cancer/end-of-life. The impressive results offer much hope for an effective treatment to heal “hearts and minds.
Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.
The Psychedelic Research Group focuses on two main areas: first, the action of psychedelic drugs in the brain and second, their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression.
Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.
The information offered here is not a substitute for professional advice. Please proceed with care and caution.
To continue customizing your FindCenter experience, create an account. It’s free!
Create an account to discover wisdom, save your favorite content, and connect with teachers and seekers.
IT’S FREE
If you already have an account, please log in.